Sutro Biopharma
Price & Volume
Stats
See moreOpen | $3.89 |
Previous Close | $3.92 |
Day Range | $3.78-$3.93 |
52W Range | $2.00-$6.13 |
Market Cap | $321.2M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $169.3M |
Revenue Growth (YoY) | 146.9% |
Gross Profit (12 Mos) | -$42.5M |
Diluted EPS | -$1.78 |
News
See moreYahoo Finance • 9 months ago
Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024
Yahoo Finance • 10 months ago
Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates
Yahoo Finance • 10 months ago
Sutro Biopharma Promotes Jane Chung to President and Chief Operating Officer
Yahoo Finance • 10 months ago
Sutro Biopharma Inc (STRO) Reports Q3 2023 Financial Results and Business Updates
About
CEO | Mr. William J. Newell J.D. |
CFO | Mr. Edward C. Albini M.B.A |
Address | 111 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 304 |
